vs
Side-by-side financial comparison of ACACIA RESEARCH CORP (ACTG) and Sanara MedTech Inc. (SMTI). Click either name above to swap in a different company.
ACACIA RESEARCH CORP is the larger business by last-quarter revenue ($50.1M vs $27.5M, roughly 1.8× Sanara MedTech Inc.). ACACIA RESEARCH CORP runs the higher net margin — 6.8% vs -5.9%, a 12.7% gap on every dollar of revenue. On growth, Sanara MedTech Inc. posted the faster year-over-year revenue change (4.6% vs 2.6%). Over the past eight quarters, ACACIA RESEARCH CORP's revenue compounded faster (43.6% CAGR vs 21.8%).
Acacia Research Corporation is a publicly traded American company based in New York City. It acquires and operates businesses in industries including the technology, energy, and industrial/manufacturing sectors. Acacia has a strategic relationship with Starboard Value, LP, the company's controlling shareholder. The company has been characterized as a patent troll.
Sanara MedTech Inc. is a US-based medical technology company that develops, manufactures, and distributes innovative surgical, wound care, and post-acute rehabilitation products. It mainly serves healthcare providers, hospitals, and long-term care facilities across North America, with a portfolio of FDA-cleared solutions designed to improve patient outcomes and lower clinical care operational costs.
ACTG vs SMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $50.1M | $27.5M |
| Net Profit | $3.4M | $-1.6M |
| Gross Margin | 12.8% | 93.2% |
| Operating Margin | -26.1% | 23.5% |
| Net Margin | 6.8% | -5.9% |
| Revenue YoY | 2.6% | 4.6% |
| Net Profit YoY | 125.5% | 5.3% |
| EPS (diluted) | $0.03 | $-0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $50.1M | $27.5M | ||
| Q3 25 | $59.4M | $26.3M | ||
| Q2 25 | $51.2M | $25.8M | ||
| Q1 25 | $124.4M | $23.4M | ||
| Q4 24 | $48.8M | $26.3M | ||
| Q3 24 | $23.3M | $21.7M | ||
| Q2 24 | $25.8M | $20.2M | ||
| Q1 24 | $24.3M | $18.5M |
| Q4 25 | $3.4M | $-1.6M | ||
| Q3 25 | $-2.7M | $-30.4M | ||
| Q2 25 | $-3.3M | $-2.0M | ||
| Q1 25 | $24.3M | $-3.5M | ||
| Q4 24 | $-13.4M | $-1.7M | ||
| Q3 24 | $-14.0M | $-2.9M | ||
| Q2 24 | $-8.4M | $-3.5M | ||
| Q1 24 | $-186.0K | $-1.8M |
| Q4 25 | 12.8% | 93.2% | ||
| Q3 25 | 21.2% | 92.9% | ||
| Q2 25 | 12.8% | 92.5% | ||
| Q1 25 | 47.4% | 92.2% | ||
| Q4 24 | 17.6% | 91.4% | ||
| Q3 24 | 10.1% | 90.8% | ||
| Q2 24 | 26.2% | 90.0% | ||
| Q1 24 | 49.2% | 89.8% |
| Q4 25 | -26.1% | 23.5% | ||
| Q3 25 | -10.8% | 11.2% | ||
| Q2 25 | -24.2% | -0.1% | ||
| Q1 25 | 30.8% | -8.9% | ||
| Q4 24 | -32.4% | 18.6% | ||
| Q3 24 | -44.1% | 3.6% | ||
| Q2 24 | -18.4% | -14.3% | ||
| Q1 24 | -8.6% | -8.3% |
| Q4 25 | 6.8% | -5.9% | ||
| Q3 25 | -4.6% | -115.5% | ||
| Q2 25 | -6.4% | -7.8% | ||
| Q1 25 | 19.5% | -15.1% | ||
| Q4 24 | -27.5% | -6.5% | ||
| Q3 24 | -60.0% | -13.2% | ||
| Q2 24 | -32.7% | -17.4% | ||
| Q1 24 | -0.8% | -9.5% |
| Q4 25 | $0.03 | $-0.32 | ||
| Q3 25 | $-0.03 | $-3.40 | ||
| Q2 25 | $-0.03 | $-0.23 | ||
| Q1 25 | $0.25 | $-0.41 | ||
| Q4 24 | $-0.14 | $-0.18 | ||
| Q3 24 | $-0.14 | $-0.34 | ||
| Q2 24 | $-0.08 | $-0.41 | ||
| Q1 24 | $0.00 | $-0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $306.7M | $16.6M |
| Total DebtLower is stronger | $91.9M | $46.0M |
| Stockholders' EquityBook value | $543.5M | $5.9M |
| Total Assets | $771.0M | $72.9M |
| Debt / EquityLower = less leverage | 0.17× | 7.74× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $306.7M | $16.6M | ||
| Q3 25 | $301.8M | $14.9M | ||
| Q2 25 | $316.7M | $17.0M | ||
| Q1 25 | $272.0M | $20.7M | ||
| Q4 24 | $273.9M | $15.9M | ||
| Q3 24 | $410.9M | $16.3M | ||
| Q2 24 | $441.9M | $6.2M | ||
| Q1 24 | $498.4M | $2.8M |
| Q4 25 | $91.9M | $46.0M | ||
| Q3 25 | — | $45.1M | ||
| Q2 25 | — | $44.2M | ||
| Q1 25 | — | $43.4M | ||
| Q4 24 | — | $30.7M | ||
| Q3 24 | — | $30.1M | ||
| Q2 24 | — | $14.4M | ||
| Q1 24 | — | $9.7M |
| Q4 25 | $543.5M | $5.9M | ||
| Q3 25 | $537.6M | $6.1M | ||
| Q2 25 | $538.6M | $35.4M | ||
| Q1 25 | $540.2M | $36.7M | ||
| Q4 24 | $514.8M | $39.4M | ||
| Q3 24 | $540.2M | $39.8M | ||
| Q2 24 | $560.7M | $41.7M | ||
| Q1 24 | $568.3M | $43.3M |
| Q4 25 | $771.0M | $72.9M | ||
| Q3 25 | $768.9M | $71.1M | ||
| Q2 25 | $775.5M | $98.8M | ||
| Q1 25 | $801.6M | $96.4M | ||
| Q4 24 | $756.4M | $88.1M | ||
| Q3 24 | $707.6M | $88.5M | ||
| Q2 24 | $753.6M | $73.4M | ||
| Q1 24 | $631.7M | $70.9M |
| Q4 25 | 0.17× | 7.74× | ||
| Q3 25 | — | 7.33× | ||
| Q2 25 | — | 1.25× | ||
| Q1 25 | — | 1.18× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | 0.76× | ||
| Q2 24 | — | 0.34× | ||
| Q1 24 | — | 0.22× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $75.2M | $3.9M |
| Free Cash FlowOCF − Capex | — | $3.9M |
| FCF MarginFCF / Revenue | — | 14.0% |
| Capex IntensityCapex / Revenue | — | 0.3% |
| Cash ConversionOCF / Net Profit | 22.01× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $2.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $75.2M | $3.9M | ||
| Q3 25 | $9.5M | $2.2M | ||
| Q2 25 | $50.1M | $2.7M | ||
| Q1 25 | $2.4M | $-2.0M | ||
| Q4 24 | $50.1M | $932.0K | ||
| Q3 24 | $-593.0K | $2.1M | ||
| Q2 24 | $16.1M | $-1.4M | ||
| Q1 24 | $54.8M | $-1.6M |
| Q4 25 | — | $3.9M | ||
| Q3 25 | — | $1.1M | ||
| Q2 25 | — | $902.7K | ||
| Q1 25 | $335.0K | $-3.7M | ||
| Q4 24 | $-98.5M | $859.9K | ||
| Q3 24 | $-2.8M | $2.0M | ||
| Q2 24 | $-126.7M | $-1.5M | ||
| Q1 24 | $54.6M | $-1.7M |
| Q4 25 | — | 14.0% | ||
| Q3 25 | — | 4.2% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | 0.3% | -15.9% | ||
| Q4 24 | -201.8% | 3.3% | ||
| Q3 24 | -12.1% | 9.4% | ||
| Q2 24 | -490.5% | -7.3% | ||
| Q1 24 | 224.4% | -9.0% |
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 4.0% | ||
| Q2 25 | — | 6.8% | ||
| Q1 25 | 1.7% | 7.4% | ||
| Q4 24 | 304.4% | 0.3% | ||
| Q3 24 | 9.6% | 0.0% | ||
| Q2 24 | 553.0% | 0.3% | ||
| Q1 24 | 1.1% | 0.4% |
| Q4 25 | 22.01× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.10× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACTG
| Energy Operations | $16.0M | 32% |
| Transportation Safety | $10.4M | 21% |
| Office Storage And Display Solutions | $8.4M | 17% |
| Printers Consumables And Parts | $6.5M | 13% |
| Natural Gas Reserves | $5.1M | 10% |
| Natural Gas Liquids Reserves | $3.3M | 7% |
SMTI
| Soft Tissue Repair Products | $24.7M | 90% |
| Bone Fusion Products | $2.8M | 10% |
